Cannabis company Tilray Brands (NASDAQ:TLRY) missed Wall Street’s revenue expectations in Q2 CY2025, with sales falling 2.3% ...

Shares of the cannabis producer have been rallying, but they are still nowhere near the levels they were at a few years ago.

Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More » Two stocks that have been exceptionally h ...

Tilray Brands (TLRY) stock tumbles after Q4 2025 revenue miss; its cannabis rivals including Canopy (CGC), Aurora Cannabis ...

Shares of Tilray Brands (NASDAQ: TLRY) tumbled 14.2% through 12:15 p.m. ET after the company reported mixed fiscal Q4 2025 ...

Tilray Brands Inc (TLRY) reports a robust quarter with significant international growth and improved financial metrics ...

Roth Capital Markets analyst Bill Kirk maintained a “Neutral” rating and lowered his 12-month price target to $0.60 from ...

Cannabis company Tilray Brands (NASDAQ:TLRY) will be announcing earnings results this Monday afternoon. Here’s what you need to know.

Fiscal Year Net Revenue of $821 Million, $834 Million in Constant Currency, Strategic Decisions Impacted Revenue by $35 Million Q4 Consolidated Adjusted EBITDA is the 2nd Highest in the Company’s ...

As per the Seeking Alpha's Quant Ratings, TLRY has a Hold rating with a score of 2.61 out of 5. The company received an A for growth and a B grade for profitability, but a C- grade in momentum as well ...

Tilray Brands Inc. (NASDAQ:TLRY) is one of the best penny stocks under $1 to buy now. On June 26, Tilray Brands, through its medical division, Tilray Medical, published a new scientific study on the ...

For the full fiscal year 2025, Tilray achieved record revenue of $821.3 million, representing a 4% increase from the previous year. The company’s cannabis segment saw gross margin expansion of 700 ...